Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is the preferred total neoadjuvant therapy (TNT) regimen, according to a study published online Sept. 11 in the Annals of Oncology to coincide with the European Society for Medical Oncology Congress 2024, being held from Sept. 13 to 17 in Barcelona, Spain.

Aron Bercz, M.D., from Memorial Sloan Kettering Cancer Center in New York City, and colleagues examined potential differences in organ preservation in rectal cancer between TNT regimens integrating LCCRT and short-course radiotherapy (SCRT), the latter of which was introduced in response to the COVID-19 pandemic. The analyses included 323 locally advanced rectal adenocarcinoma patients treated with LCCRT (247 patients) and SCRT (76 patients) from January 2018 to January 2021. Organ preservation with watch-and-wait (WW) management was offered to patients who achieved clinical complete response.

Patients were followed for a median of 31 months. The researchers found similar clinical complete response rates after LCCRT and SCRT (44.5 versus 43.4 percent). Among patients treated with LCCRT and SCRT, two-year organ preservation was 40 and 31 percent, respectively. In patients managed with WW, compared with SCRT, LCCRT resulted in higher two-year organ preservation (89 versus 70 percent) and lower two-year local regrowth (19 versus 36 percent). WW patients treated with LCCRT and SCRT had similar two-year distant recurrence (10 versus 6 percent), disease-free survival (90 versus 90 percent), and overall survival (99 versus 100 percent).

"These findings provide timely insights for patients considering organ preservation strategies and support induction LCCRT followed by consolidation chemotherapy as the preferred TNT regimen," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-13 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords